ReviewAdvances in experimental medicine and biology2025
Metabolic Implications of Efferocytosis During Inflammation.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Every day billions of cells are removed in the human body by apoptosis. These apoptotic cells need to be rapidly and safely removed in order to avoid inflammation. This is ensured by a process called efferocytosis, where professional phagocytes such as macrophages take up apoptotic cells. Efferocytosis not only ensures the safe removal of cellular debris but also endows phagocytes with the capacity to actively contribute to the resolution of inflammation by altering their phenotype. Therefore, actively promoting efferocytosis may contribute to the resolution of auto-inflammatory disease conditions. While the initial steps of the recognition of dying cells by macrophages are well investigated, it is less clear what happens to the ingested material inside the phagocyte and how it influences their pro-resolving properties. In this chapter, we therefore briefly discuss the impact of efferocytosis during inflammation. We focus on the metabolic challenge macrophages face when removing multiple dying cells, e.g., during inflammation, and how the knowledge resulting from understanding the molecular programs that promote corpse digestion might be used in the future to combat inflammatory diseases in humans.
Indexed as
Identifiers
41004081What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.